Strategy Asset Managers »

Biogen Idec shares owned by Strategy Asset Managers

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Strategy Asset Managers from 13F filings

Historical chart of Strategy Asset Managers investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Strategy Asset Managers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Strategy Asset Managers

Quarter filed Position value Share count Share price at filing
2026-09-30 $885k 3.9k 225.88

More positions owned by Strategy Asset Managers

Microsoft Corporation (MSFT)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Cisco Systems (CSCO)
Johnson & Johnson (JNJ)
Apple (AAPL)
Emerson Electric (EMR)
Lockheed Martin Corporation (LMT)
Chevron Corporation (CVX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Kinder Morgan (KMI)
Ishares Tr Core S&p500 Etf (IVV)
Texas Instruments Incorporated (TXN)

View all positions for Strategy Asset Managers

Top funds holding Biogen Idec

FMR
BlackRock
PRIMECAP Management Company
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management
Wellington Management Company
Norges Bank Investment Management
AQR Capital Management
Jpmorgan Chase & Co
Invesco
Susquehanna International
UBS Group
Amundi
Legal & General Group

View all funds holding Biogen Idec